SINOVAC BIOTECH LTD (SVA) Operating margin 2016–2025
SINOVAC BIOTECH LTD (SVA) operating margin by fiscal year — reported operating income divided by reported revenue.
-127.0%FY2025 · since FY2016: 0.7% → -127.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -127.0% | +12.9 pp |
| FY2024 | -139.9% | +12.0 pp |
| FY2023 | -151.9% | -117.3 pp |
| FY2022 | -34.5% | -125.5 pp |
| FY2021 | 91.0% | +48.7 pp |
| FY2020 | 42.2% | +14.4 pp |
| FY2019 | 27.9% | +8.1 pp |
| FY2018 | 19.7% | -6.3 pp |
| FY2017 | 26.0% | +25.4 pp |
| FY2016 | 0.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice